Ben Park, MD, PhD, is the director of the Vanderbilt-Ingram Cancer Center, the Benjamin F. Byrd, Jr. Chair in oncology, and professor of medicine in the division of hematology/oncology at the Vanderbilt University Medical Center in Nashville. Dr. Park’s research is dedicated to finding a cure for all types of breast cancer by investigating mutated and altered genes. In particular, Dr. Park has pioneered the use of liquid biopsies to help guide future management of breast cancer therapies.
When liquid biopsy was first introduced in 2010, it was hailed as a revolutionary way to guide cancer treatment. Now,…
